References
- Picard JY, Belville C. Genetics and molecular pathology of anti-Mullerian hormone and its receptor. J Soc Biol 2002;196:217–21
- Deffieux X, Antoine JM. Inhibins, activins and anti-Mullerian hormone: structure, signalling pathways, roles and predictive value in reproductive medicine. Gynecol Obstet Fertil 2003;31:900–11
- Crisosto N, Codner E, Maliqueo M, et al. Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:2739–43
- La Marca A, De Leo V, Giulini S, et al. Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. J Soc Gynecol Investig 2005;12:545–8
- Fanchin R, Schonäuer LM, Righini C, et al. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003;18:323–7
- de Vet A, Laven JS, de Jong FH, et al. Anti-Müllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357–62
- Ledger WL. Clinical utility of measurement of anti-Mullerian hormone in reproductive endocrinology. J Clin Endocrinol Metab 2010;95:5144–54
- Chaveeva P, Carbone IF, Syngelaki A, et al. Contribution of method of conception on pregnancy outcome after the 11–13 weeks scan. Fetal Diagn Ther 2011;30:9–22
- Yarde F, Maas AH, Franx A, et al. Serum AMH levels in women with a history of preeclampsia suggest a role for vascular factors in ovarian ageing. J Clin Endocrinol Metab 2014;99:579–86
- Khalil A, Syngelaki A, Maiz N, et al. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol 2013;42:634–43
- Robinson HP, Fleming JE. A critical evaluation of sonar crown rump length measurements. Br J Obstet Gynaecol 1975;182:702–10
- Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7–15
- Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV
- Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol 2012;10:77
- Sowersand MR, LaPietra MT. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol Rev 1995;17:287–302
- Mattison DR, Thorgeirsson SS. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet 1978;1:187–8
- Paszkowski T, Clarke RN, Hornstein MD. Smoking induces oxidative stress inside the Graafian follicle. Human Reprod 2002;17:921–5
- Valdez KE, Petroff BK. Potential roles of the aryl hydrocarbon receptor in female reproductive senescence. Reprod Biol 2004;4:243–58
- Zenzes MT, Puy LA, Bielecki R. Immunodetection of cotinine protein in granulosa-lutein cells of women exposed to cigarette smoke. Fertil Steril 1997;68:76–82
- Bordel R, Laschke MW, Menger MD, Vollmar B. Nicotine does not affect vascularization but inhibits growth of freely transplanted ovarian follicles by inducing granulosa cell apoptosis. Human Reprod 2006;21:610–17
- Tal R, Seifer DB. Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve. Int J Endocrinol 2013;2013:818912
- Seifer DB, MacLaughlin DT, Cuckle HS. Serum Mullerian-inhibiting substance in Down’s syndrome pregnancies. Hum Reprod 2007;22:1017–20
- Plante BJ, Beamon C, Schmitt CL, et al. Maternal anti-Mullerian hormone levels do not predict fetal aneuploidy. J Assist Reprod Genet 2010;27:409–14
- Köninger A, Kauth A, Schmidt B, et al. Anti-Mullerian-hormone levels during pregnancy and postpartum. Reprod Biol Endocrinol 2013;11:60
- Akolekar R, Syngelaki A, Poon L, et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013;33:8–15